Juergen Siebler

443 total citations
18 papers, 343 citations indexed

About

Juergen Siebler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Juergen Siebler has authored 18 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Juergen Siebler's work include Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Juergen Siebler is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Juergen Siebler collaborates with scholars based in Germany, Switzerland and United States. Juergen Siebler's co-authors include Peter R. Galle, Markus F. Neurath, Markus Moehler, Timo Räth, Francesco Vitali, Andreas Naegel, Michael Heike, Stefan Wirtz, Dimitri Flieger and A. Wein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Juergen Siebler

18 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juergen Siebler Germany 11 166 154 78 67 59 18 343
Jean‐Pierre Duffas France 6 285 1.7× 150 1.0× 259 3.3× 27 0.4× 35 0.6× 8 445
George Margantinis Greece 10 104 0.6× 111 0.7× 191 2.4× 41 0.6× 44 0.7× 14 296
W Bohle Germany 10 106 0.6× 110 0.7× 113 1.4× 17 0.3× 53 0.9× 39 324
Ouki Yasui Japan 11 130 0.8× 90 0.6× 171 2.2× 29 0.4× 16 0.3× 30 363
Kai Mi China 5 99 0.6× 91 0.6× 154 2.0× 36 0.5× 17 0.3× 8 326
A Minardi Italy 8 97 0.6× 64 0.4× 139 1.8× 69 1.0× 36 0.6× 14 360
Lola‐Jade Palmieri France 11 165 1.0× 53 0.3× 79 1.0× 29 0.4× 18 0.3× 35 297
Keisuke Okuno Japan 11 133 0.8× 112 0.7× 93 1.2× 22 0.3× 34 0.6× 42 310
Masaki Taruishi Japan 8 170 1.0× 193 1.3× 127 1.6× 55 0.8× 27 0.5× 22 338

Countries citing papers authored by Juergen Siebler

Since Specialization
Citations

This map shows the geographic impact of Juergen Siebler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Siebler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Siebler more than expected).

Fields of papers citing papers by Juergen Siebler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Siebler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Siebler. The network helps show where Juergen Siebler may publish in the future.

Co-authorship network of co-authors of Juergen Siebler

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Siebler. A scholar is included among the top collaborators of Juergen Siebler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Siebler. Juergen Siebler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Vitali, Francesco, Andreas Naegel, Raja Atreya, et al.. (2019). Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding. World Journal of Gastroenterology. 25(13). 1592–1602. 35 indexed citations
2.
Vitali, Francesco, Andreas Naegel, Juergen Siebler, Markus F. Neurath, & Timo Räth. (2018). Endoscopic full-thickness resection with an over-the-scope clip device (FTRD) in the colorectum: results from a university tertiary referral center. SHILAP Revista de lepidopterología. 6(1). E98–E103. 37 indexed citations
3.
4.
Kohl, Matthias, et al.. (2017). Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study. Supportive Care in Cancer. 26(3). 843–851. 19 indexed citations
5.
6.
Ganslmayer, Marion, Alexander Hagel, Wolfgang Dauth, et al.. (2014). A large cohort of patients with hepatocellular carcinoma in a single European centre: aetiology and prognosis now and in a historical cohort. Swiss Medical Weekly. 144(304). w13900–w13900. 10 indexed citations
7.
Wein, Axel, Frank Boxberger, Juergen Siebler, et al.. (2013). Efficacy and toxicity of second-line AIO plus irinotecan (IRI) after pretreatment with AIO plus oxaliplatin (L-OHP) in the sequential therapy of metastatic colorectal cancer (CRC).. Journal of Clinical Oncology. 31(15_suppl). 3561–3561. 2 indexed citations
8.
Neurath, Markus F., Heike Dornhoff, & Juergen Siebler. (2011). Potential role of interferon-lambda in the treatment of inflammation and cancer: an update. 51–51. 2 indexed citations
9.
Moehler, Markus, Martin F. Sprinzl, Carl C. Schimanski, et al.. (2009). Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. World Journal of Gastroenterology. 15(4). 449–449. 34 indexed citations
10.
Siebler, Juergen, Stefan Wirtz, Christian Frenzel, et al.. (2008). Cutting Edge: A Key Pathogenic Role of IL-27 in T Cell- Mediated Hepatitis. The Journal of Immunology. 180(1). 30–33. 36 indexed citations
11.
Siebler, Juergen, et al.. (2007). Enhanced Sensitivity to CD95-Induced Apoptosis in ob/ob Mice. Digestive Diseases and Sciences. 52(9). 2396–2402. 11 indexed citations
12.
Siebler, Juergen, Stefan Wirtz, Benno Weigmann, et al.. (2006). IL-28A Is a Key Regulator of T-Cell–Mediated Liver Injury via the T-Box Transcription Factor T-Bet. Gastroenterology. 132(1). 358–371. 36 indexed citations
13.
Moehler, Markus, Juergen Siebler, Thomas Höhler, et al.. (2005). Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. British Journal of Cancer. 92(12). 2122–2128. 77 indexed citations
14.
Moehler, Markus, Juergen Siebler, Thomas Hoehler, et al.. (2004). CPT11/FA/5-FU versus ELF in chemonaive patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: A randomized phase II study. Journal of Clinical Oncology. 22(14_suppl). 4064–4064. 1 indexed citations
15.
Moehler, Markus, Juergen Siebler, Thomas Hoehler, et al.. (2004). CPT11/FA/5-FU versus ELF in chemonaive patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: A randomized phase II study. Journal of Clinical Oncology. 22(14_suppl). 4064–4064. 1 indexed citations
16.
Moehler, Markus, Juergen Siebler, C Schimanski, et al.. (2003). Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer. Anti-Cancer Drugs. 14(8). 645–650. 16 indexed citations
17.
Siebler, Juergen, Stefan Wirtz, Martina Protschka, et al.. (2003). 193 Interferon γ signaling pathway plays a key role in CON a induced liver injury. Hepatology. 38. 249–249. 1 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Duffas Breakdown of academic impact, for papers by George Margantinis Breakdown of academic impact, for papers by W Bohle Breakdown of academic impact, for papers by Ouki Yasui Breakdown of academic impact, for papers by Kai Mi Breakdown of academic impact, for papers by A Minardi Breakdown of academic impact, for papers by Lola‐Jade Palmieri Breakdown of academic impact, for papers by Keisuke Okuno Breakdown of academic impact, for papers by Masaki Taruishi
Rankless by CCL
2026